Healthtech Startups

Synyi (Shanghai Synyi Intelligent Information Technology), founded in 2016, develops AI, large language models, and big-data technologies for healthcare, offering more than 20 AI medical solutions covering clinical diagnosis and quality control, hospital operations management, and clinical research. It serves hospitals, medical alliances, healthcare companies, and health regulators, primarily in China, and is headquartered in Shanghai.

2 investors

Predisease sells physician-recommended dietary supplement capsules and sachets through a mail-order system, with products targeting cholesterol, blood sugar, joint pain, menopause symptoms, and immunity. Orders are placed via a physician PPN reference and include automatic refills under a money-back efficacy guarantee.

1 investor

C&R Research is a contract research organization providing end-to-end clinical trial services, including regulatory and non-regulatory trials as well as multinational studies. It has conducted around 1,800 clinical trials, including 79 global multinational trials, over 29 years.

1 investor

Alivas is a medical device startup developing a new therapeutic device for refractory chronic constipation, a condition affecting patients who do not respond to drug treatment. The company originated from the Japan Biodesign program, a collaboration between Stanford University and the University of Tokyo.

1 investor

Epsilon Medical develops and manufactures intravascular electrodes for cerebrovascular applications. The company operates in the medical device sector, serving clinical and research markets.

1 investor

TL Genomics develops in vitro diagnostic medical products and healthcare testing services, focusing on bone marrow transplant testing, chromosome analysis for disease risk and fertility assessment, and related medical services.

1 investor

Cellusion is a regenerative medicine company developing innovative technologies and products based on patient-centric research across disease areas where regenerative medicine can create new therapeutic value.

1 investor

ANDBAM sells a shampoo and conditioner combo formulated to address hair loss and scalp health through active ingredients like DHT blockers and growth stimulants. The products target consumers seeking thicker, fuller hair through a direct-to-consumer model.

1 investor

101mobility provides bathroom safety equipment and modification services designed to reduce fall risks and support independent living for elderly and mobility-impaired individuals.

1 investor

10x provides an AI-powered back-office service that automates dental practice operations including hygiene recall outreach, treatment follow-up coordination, and missed-call answering. The system uses conversational AI to contact patients via text or phone and book appointments directly into practice management systems.

1 investor

119 is a patent-pending mobile and wearable system that acts as a modern medical ID, communicating a user's medical information to bystanders or first responders via QR code and guiding them through the appropriate emergency response. It serves people with chronic health conditions, offering pre-set emergency messaging and a bystander questionnaire to avoid unnecessary 911 calls.

1 investor

123Dentist operates a network of neighbourhood dental clinics across Canada, offering services from routine cleanings and checkups to orthodontics, dental implants, teeth whitening, emergency care, and children's dentistry. It helps patients find local clinics, arrange appointments, and manage payment through insurance, patient financing, and the Canadian Dental Care Plan.

1 investor

Kalguroo is a Thai AI-powered calorie-counting app that analyzes food photos to provide nutritional data, leveraging multimodal AI and a proprietary Thai food database. The app is expanding toward a comprehensive personal health coaching platform serving users globally, with a focus on Southeast Asian markets.

1 investor

1928 Diagnostics provides a cloud-based bioinformatics platform that transforms complex genomic sequencing data into actionable insights for researchers, healthcare providers, and organizations. The platform automates genomic analysis workflows, making advanced analytics accessible without requiring specialized computational expertise or on-site infrastructure.

1 investor

19Labs builds GALE, a smart point-of-care platform that brings a full clinic experience to schools, rural communities, and pharmacies. The company focuses on providing telemedicine and healthcare access to underserved rural populations worldwide.

1 investor

One Mnet Health provides technology and services that turn healthcare data into insights for healthcare providers, supporting workflow automation, patient engagement, personalized care, and revenue and payment management. It serves providers across the United States, helping manage patient balances and improve operational efficiency.

1 investor

1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines. Its lead project is a salbutamol inhaler for asthma relief, with potential applications in rescue medications, anaphylaxis, migraine, vaccines and clinical trials.

1 investor

20n uses machine learning and computational biology to predict DNA sequences for industrial biotech and pharmaceutical applications. The company serves manufacturing firms developing biologically-based alternatives to traditional chemical production of fuels, materials, therapeutics, and specialty chemicals.

1 investor

2bull MeDiTherapy develops in-vitro diagnostic medical devices, including TAP, a blood test designed to detect thoracic and abdominal aortic aneurysms. The company focuses on early detection and monitoring diagnostics for cardiovascular disease.

1 investor

1 investor

2cureX develops IndiTreat®, a 3D functional precision medicine test that grows patient-derived cancer cells as 3D microtumors (tumoroids) from a tumor biopsy to profile drug sensitivity and guide individualized therapy selection. The company serves oncologists and healthcare professionals, providing drug-response reports to inform cancer treatment decisions, and brings its diagnostic products through EU regulatory and reimbursement pathways.

1 investor

2EyesVision develops ophthalmic simulation technology for patients to experience presbyopic and cataract corrections before surgery. The company commercializes medical devices and software solutions addressing age-related vision conditions affecting large patient populations globally.

1 investor

3Sunny provides SaaS-based web services for healthcare and long-term care facilities in Japan to address staffing shortages and rising operational costs in the medical and nursing care sectors.

1 investor

A biotech company focused on microbiome and metabolomics research for gastrointestinal health applications, with leadership and scientific advisory rooted in academic medicine and regulatory expertise.

1 investor